Immediate and long-term portal hemodynamic consequences of small- diameter H-graft portacaval shunt

Journal of Surgical Research

Volumn 74, Issue 1, 1998, Pages 71-75

  Zervos, Emmanuel E ^a   Goode, Sarah E ^a   Rosemurgy, Alexander S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CHOLESTEROL; GALACTOSE;

BRAIN DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; FOLLOW UP; HEPATIC ARTERY; HUMAN; LIVER BLOOD FLOW; LIVER FUNCTION; LIVER GRAFT; PORTAL VEIN BLOOD PRESSURE; PORTOCAVAL SHUNT; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0031814494     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5194     Document Type: Conference Paper

References (29)

1. Sarfeh J., Rypins E. B. The emergency portacaval H graft in alcoholic cirrhotic patients: Influence of shunt diameter on clinical outcome. Am. J. Surg. 152:1986;290.
2. Sarfeh J., Rypins E. B. Partial versus total portacaval shunt in alcoholic cirrhosis. Ann. Surg. 219:1994;353.
3. Rypins E. B., Milne N., Sarfeh J. Analysis of nutrient hepatic blood flow after 8-mm versus 16-mm portacaval H-grafts in a prospective randomized trial. Am. J. Surg. 169:1995;197.
4. Warren W. D., Millikan W. J., Henderson J. M., Wright L., Kutner M., Smith R., Fulenwider T., Salam A., Galambos J. T. Ten years portal hypertensive surgery at Emory: Results and new perspectives. Ann. Surg. 195:1992;530.
5. Rikkers L. F. New concepts of pathophysiology and treatment of portal hypertension. Surgery. 107:1990;481.
6. Chandler J. G. The history of the surgical treatment of portal hypertension. Arch. Surg. 128:1993;925.
7. Hermann R. E., Henderson J. M., Vogt D. P., Mayes J. T., Geisinger M. A., Agnor C. Fifty years of surgery for portal hypertension at the Cleveland clinic foundation. Ann. Surg. 221:1995;459.
8. Zeppa R., Lee P., Hutson D., Levi J., Livingstone A. Portal hypertension: A fifteen year perspective. Am. J. Surg. 155:1988;6.
9. Sarfeh J., Rypins E. B., Mason G. R. A systematic appraisal of portacaval H-graft diameters: Clinical and hemodynamic perspectives. Ann. Surg. 204:1986;356.
10. Sarfeh J., Rypins E. B., Conroy R. M., Mason G. R. Portocaval H-graft: Relationship of shunt diameter, portal flow patterns and encephalopathy. Ann. Surg. 197:1983;422.
11. Rosemurgy A. S., McAllister E. W., Kearney R. E. Prospective study of a prosthetic H-graft portacaval shunt. Am. J. Surg. 161:1991;159.
12. Capussotti L., Vergara V., Polastri R., Marucci M. M., Bouzari H., Fava C. A critical appraisal of the small-diameter portacaval H-graft. Am. J. Surg. 170:1995;10.
13. Rosemurgy A. S., Zervos E. E., Zwiebel B., Black T., Goode S. A prospective study comparing effective hepatic blood flow after TIPS and H-graft portacaval shunt. Ann. Surg. 225:1997;601.
14. Zervos E. E., Goode S., Rosemurgy A. S. Small diameter H-graft portacaval shunt reduces portal pressure yet maintains effective hepatic blood flow. Am. Surg. 64:1998.
15. Godellas C. V., Fabri P. J., Knierim T. H., Rosemurgy A. S., Gower W. R. Hepatic function after porto-systemic shunt. J. Surg. Res. 52:1992;157.
16. Rosemurgy A. S., McAllister E. W., Godellas C. V., Goode S., Albrink M. H., Fabri P. J. The effect of partial portal decompression on portal blood flow and effective hepatic blood flow in man: A prospective study. J. Surg. Res. 59:1995;627.
17. Pollack G. M., Brouwer K., Demby K., Jones J. Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose. Drug Met. Disp. 18:1990;197.
18. Soper N., Rikkers L. F., Davis E. Hepatic blood flow measurement: Comparison of indocyanine green and low-dose galactose clearance techniques. Curr. Surg. 41:1984;455.
19. Zaramella M., Vallini R., Tiribelli C. Estimation of the hepatic blood flow by galactoseplasma clearance in patients with liver disease. Liver. 5:1995;129.
20. Hanna S. Measurement of liver blood flow by galactose clearance. Can. J. Surg. 27:1984;218.
21. Schirmer W. J., Townsend M. C., Schirmer J., Hampton W., Fry D. Galactose clearance as an estimate of effective hepatic blood flow: Validation and limitations. J. Surg. Res. 41:1986;543.
22. Henderson J. M., Hanna S. Effective liver blood flow: Determination by galactose clearance. Can. J. Surg. 26:1983;129.
23. Rosemurgy A. S. Small diameter interposition shunt. Mastery of Surgery. 1996;Little, Brown and Company, Boston. p. 1301-1307.
24. Henderson J. M., Fales F. W. Continuous-flow fluorometry of low galactose concentrations in blood and plasma. Clin. Chem. 26:1980;282.
25. Rypins E. B., Sankary H., Wynn M. J. Bedside micro-method for measuring effective hepatic blood flow, with use of first-order galactose clearance pharmacokinetics. Clin. Chem. 31:1985;1557.
26. Levi J. U., Zeppa R., Hutson D. G. Early hemodynamic effects of the distal splenorenal shunt. Surg. Forum. 27:1976;370.
27. Reichle F. A., Owen O. E. Hemodynamic patterns in human hepatic cirrhosis: A prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts. Ann. Surg. 190:1979;523.
28. Gelman S., Aldrete J. S., Halpern N. Hemodynamics during portacaval shunt surgery in humans. Anesth. Analg. 61:1982;185.
29. Colombato L. A., Spahr L., Martinet J. P., Dufresne M. P., Lafortune M., Fenyves D., Pomier-Layrargues G. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut. 39:1996;600.